Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorPineros, Marion
dc.contributor.authorGinsburg, Ophira
dc.contributor.authorBendahhou, Karima
dc.contributor.authorEser, Sultan
dc.contributor.authorShelpai, Wael A.
dc.contributor.authorFouad, Heba
dc.contributor.authorZnaor, Ariana
dc.contributor.authorStaging Survey Grp
dc.date.accessioned2023-07-17T11:07:09Z
dc.date.available2023-07-17T11:07:09Z
dc.date.issued2022en_US
dc.identifier.issn1877-7821 / 1877-783X
dc.identifier.urihttps://doi.org/10.1016/j.canep.2022.102250
dc.identifier.urihttps://hdl.handle.net/20.500.12462/13219
dc.descriptionEser, Sultan (Balikesir Author)en_US
dc.description.abstractBackground: Availability of stage information by population-based cancer registries (PBCR) remains scarce for diverse reasons. Nevertheless, stage is critical cancer control information particularly for cancers amenable to early detection. In the framework of the Global Initiative for Cancer Registry Development (GICR), we present the status of stage data collection and dissemination among registries in the Middle East and Northern Africa (MENA) region as well as the stage distribution of breast cancer patients. Methods: A web-based survey exploring staging practices and breast cancer stage was developed and sent to 30 PBCR in 18 countries of the MENA region. Results: Among 23 respondent PBCR, 21 collected stage data, the majority (80%) for all cancers. Fourteen registries used a single classification (9 TNM and 5 SEER), 7 used both staging systems in parallel. Out of 12,888 breast cancer patients (seven registries) 27.7% had unknown TNM stage (11.1% in Oman, 46% in Annaba). When considering only cases with known stage, 65.3% were early cancers (TNM I+II), ranging from 57.9% in Oman to 83.3% in Batna (Algeria), and 9.9% were stage IV cancers. Among the nine registries providing SEER Summary stage for breast cancer cases, stage was unknown in 19% of the cases, (0 in Bahrain, 39% in Kuwait). Stage data were largely absent from the published registry reports. Conclusion: Despite wide stage data collection by cancer registries, missing information and low dissemination clearly limit informing efforts on early detection. The use of two classification systems in parallel implies additional workload and might undermine completeness. The favourable results of early cancer (TNM I+II) in two thirds of breast cancer patients needs to be interpreted with caution and followed up in time. Although efforts to improve quality of stage data are needed, our findings are particularly relevant to the WHO Global Breast Cancer Initiative.en_US
dc.description.sponsorshipUnion for International Cancer Control, Switzerland (UICC) Friends of Cancer Patients, United Arab Emirates (FOCP)en_US
dc.language.isoengen_US
dc.publisherElsevier Sci Ltden_US
dc.relation.isversionof10.1016/j.canep.2022.102250en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subjectCanceren_US
dc.subjectSurveillance TNM Stagingen_US
dc.subjectNorthern Africaen_US
dc.subjectMiddle Easten_US
dc.subjectEarly Detectionen_US
dc.titleStaging practices and breast cancer stage among population-based registries in the MENA regionen_US
dc.typearticleen_US
dc.relation.journalCancer Epidemiologyen_US
dc.contributor.departmentTıp Fakültesien_US
dc.contributor.authorID0000-0003-4427-4540en_US
dc.identifier.volume81en_US
dc.identifier.issueDecemberen_US
dc.identifier.startpage1en_US
dc.identifier.endpage6en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess